Paul Daruwala, Chief Operating Officer at Cidara Therapeutics, Inc. (CDTX), sold 3,461 shares at $2.66 ($7K) on 2021-04-01, disclosed to the SEC on 2021-04-05.
Open-market sale of $7k CDTX by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.06 | 2,868 | $6K | 78.9% |
| 2 | $2.66 | 593 | $2K | 21.1% |
| Total | $2.16 avg | 3,461 | $7K | 100% |
| Filing → |
| CDTX | SELL | 2020-06-25 | $3K | — | Filing → |
| CDTX | SELL | 2020-01-06 | $8K | — | Filing → |
| CDTX | SELL | 2019-10-03 | $6K | — | Filing → |